Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy

Annals of Neurology

Volumn 48, Issue 1, 2000, Pages 121-125

  Plecko, Barbara ^a,b   Stöckler Ipsiroglu, Sylvia ^b   Paschke, Eduard ^a   Erwa, Wolfgang ^a   Struys, Eduard A ^c   Jakobs, Cornelis ^c  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; PIPECOLIC ACID; PYRIDOXINE;

ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; INFANT; MALE; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

2-AMINOADIPIC ACID; CHILD; EPILEPSY; HUMANS; INFANT, NEWBORN; MALE; PICOLINIC ACIDS; PIPECOLIC ACIDS; PYRIDOXAL PHOSPHATE; PYRIDOXINE;

EID: 0343496737     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V     Document Type: Article

References (20)

1. Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996;38:998-1006
2. 6 deficiency and dependency in man. Am J Dis Child 1967;113:109-114
3. 6-dependent epilepsy. Pediatrics 1992;90:221-223
4. Lott IT, Coulombe T, Di Paolo RV, et al. Vitamin B6-dependent seizures: pathology and chemical findings in brain. Neurology 1978;28:47-54
5. Baumeister FA, Gsell W, Shin YS, Egger J. Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics 1994;94:318-321
6. Kurlemann G, Ziegler R, Gruneberg M, et al. Disturbance of GABA metabolism in pyridoxine-dependent seizures. Neuropediatrics 1992;23:257-259
7. Kaufman KJ, Lederman JN, Wong AM, et al. A new method to detect point mutations in the gene for glutamic acid decarboxylase in patients with pyridoxine-dependent seizures. Ann Neurol 1987;22:446-447 (Abstract)
8. Kure S, Sakata Y, Miyabayashi S, et al. Mutation and polymorphic marker analyses of 65K-and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent seizures. J Hum Genet 1998;43:128-131
9. Cox PR, Dancis J. Errors of lysine metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995:1233-1238
10. Chang YF. Lysine metabolism in the human and the monkey: demonstration of pipecolic acid formation in the brain and other organs. Neurochem Res 1982;7:577-588
11. Giacobini E, Nomura Y, Schmidt-Glenewinkel T. Pipecolic acid: origin, biosynthesis and metabolism in the brain. Cell Mol Biol 1980;26:135-146
12. Fournier B, Smeitink JAM, Dorland L, et al. Peroxisomal disorders: a review. J Inherit Metab Dis 1994;17:470-486
13. Kelley RI. Quantification of pipecolic acid in plasma and urine by isotope-dilution gas chromatography/mass spectrometry. In: Hommes FA, ed. Techniques in diagnostic human biochemical genetics. New York: Wiley-Liss, 1991:205-218
14. Kok RM, Kaster L, de Long APJM, et al. Stable isotope dilution analysis of pipecolic acid in cerebrospinal fluid, plasma, urine and amniotic fluid using electron capture negative ion mass fragmentography. Clin Chim Acta 1987;168;143-152
15. Struys EA, Jakobs C. Enantiomeric analysis of D-and L-pipecolic acid in plasma using a chiral capillary gas chromatography column and mass fragmentography. J Inherit Metab Dis 1999; 22:677-678
16. 6 vitamers: cation exchange HPLC. J Nutr Biochem 1990;1:659-663
17. 2 fractions of the rat brain and the spinal cord. J Pharm Dyn 1978;1:251-255
18. 3H] GABA from brain slices of mouse cerebral cortex. Neurochem Res 1989;14:405-408
19. Gospe SM, Olin KL, Keen CL. Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet 1994;343:1133-1134
20. Bass NE, Wyllie E, Cohen B, Joseph SA. Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol 1996;11:422-444